查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133441

肺功能檢驗系統的全球市場預測(～2028年):各類型，零組件，檢驗類型，連接性，用途，終端用戶，地區的分析

Pulmonary Function Testing System Market Forecasts to 2028 - Global Analysis By Type, Component, Test Type, Component, Connectivity, Application, End User (Physical Examination Centers, Hospitals, Physician Groups ), and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

全球肺功能檢驗系統的市場規模，預計2022年為1億4,534萬美金，在預測期間內以6.4％的年複合成長率擴大，至2028年達到2億1,088萬美元。

本報告提供全球肺功能檢驗系統市場調查，市場的推動因素與阻礙因素，市場機會，COVID-19的影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢的分析

  • 促進因素
  • 阻礙因素
  • 機會
  • 威脅
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • COVID-19影響

第4章 波特的五力分析

第5章 全球肺功能檢驗系統市場:各類型

  • 完全PFT系統
  • 可攜式PFT系統

第6章 全球肺功能檢驗系統市場:各零件

  • 硬體設備
  • 軟體
  • 服務

第7章 全球肺功能檢驗系統市場:各檢驗類型

  • 肺氣數量
  • 肺活量計
  • 氣體交換檢驗
  • 高空模擬檢驗
  • 最大自願通風
  • 氧滴定檢驗
  • 聽診器
  • 尖峰吐氣流量計

第8章 全球肺功能檢驗系統市場:各技術

  • 氦氣稀釋
  • 氮氣沖洗
  • 體積描記法

第9章 全球肺功能檢驗系統市場:各用途

  • 氣喘
  • 慢性性的呼吸急促
  • 拘束性肺部疾病
  • 術前檢驗
  • 慢性阻塞性肺病
  • 障礙
  • 早晨性喘鳴

第10章 全球肺功能檢驗系統市場:各終端用戶

  • 健康檢查(診斷)中心
  • 醫院
  • 醫生群組(診療所)

第11章 全球肺功能檢驗系統市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要趨勢

  • 契約，夥伴關係，合作，合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他的主要的策略

第13章 企業簡介

  • NSPIRE HEALTH INC.
  • Koninklijke Philips N.V.
  • COSMED Srl
  • Omron Healthcare, Inc.
  • Morgan Scientific Inc.
  • Becton, Dickinson and Company.
  • Schiller AG
  • PulmOne
  • Vyaire Medical, Inc
  • Minato Holdings Inc.
  • MGC Diagnostic Corporation
  • 3M
  • Ganshorn Medizin Electronic
  • Data Sciences International
  • Medline Industries
Product Code: SMRC21929

According to Stratistics MRC, the Global Pulmonary Function Testing System Market is accounted for $145.34 million in 2022 and is expected to reach $210.88 million by 2028 growing at a CAGR of 6.4% during the forecast period. Pulmonary function testing system is a device that performs various pulmonary function tests such as respiratory mechanics, nitrogen washout, spirometry, lung volumes, vital capacity, plethysmography, and diffusion capacity. There are two types of devices available namely complete, and portable systems. These devices can be utilized to monitor people suffering from severe breathing complaints such as asthma and COPD. The systems assist in diagnosing lung disorders and selecting treatment or therapeutics for lung disorders. PFTs are extremely beneficial in recognizing the preliminary-stage irregularities in asymptomatic patients and in assessing the damage to the lungs before any signs and symptoms develop.

According to the American Cancer Society, in the United States around 228,150 new cases of lung cancer occur in 2019. Additionally, around 142,670 deaths occur from lung cancer (76,650 in men and 66,020 in women). In addition, the growing demand for minimally invasive tests to design an appropriate method of treating lung disease is supplementing the market growth. According to data by the Centers for Disease Control and Prevention (CDC), cigarette smoking is the leading cause of death in the United States. Tobacco consumption kills more than 4,80,000 Americans each year, with more than 41,000 of these deaths due to exposure to secondhand smoke.

Market Dynamics:

Driver:

Increasing prevalence of respiratory diseases

In recent years, respiratory ailments, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, and occupational lung diseases, have been the leading reasons of fatality across the globe. Furthermore, there is a considerable increase in the incidence of chronic obstructive pulmonary diseases and asthma globally, especially in developing countries. According to the Global Asthma Report 2018, in India, among 1.31 billion people, about 2% of adults and 6% of children have asthma. Such high cases of asthma are expected to increase the adoption of these systems during the forecast timeframe. In COPD and other chronic respiratory diseases, lung capacity is an important parameter. Lung capacity refers to the air volume in lungs at different respiratory cycle phases. The pulmonary function testing systems help to measure different parameters of the lungs with the help of various tests such as spirometry and plethysmography and diagnose COPD and other lung-related disorders. Such a huge occurrence of chronic respiratory diseases necessitating pulmonary function tests and the rising focus of companies to increase their presence in developing countries for these systems are expected to boost the market growth in the coming years.

Restraint:

Risk of cross contamination

Pulmonary function testing represents a potential avenue for the transmission of infection due to the congregation of patients with lung disease and the potential for coughing and droplet formation surrounding pulmonary function test procedures. These systems include mouthpieces, rebreathing valves, and tubings used in the laboratory. Mouthpieces are the most common cause of cross-infection during testing. Factors, such as exposed surface areas, quality of upholstery, general clutter, air conditioning, optimum temperature, and humidity conditions, lead to the cross-infection such as the risk of the development of tuberculosis.

Opportunity:

Shift towards portable systems from complete systems

The companies functioning in the global market incessantly emphasize on developments, such as launching portable systems with more parameters and promoting the adoption of these devices in independent clinics. These strategies shifted the espousal of complete to portable systems, thereby spurring the overall market growth. Aspects such as immobile, low cost, and presence of standard parameters, such as lung volumes, diffusion capacity, and spirometry, stimulated the healthcare facilities to shift towards portable systems.

Threat:

Lack of skilled healthcare professionals in underdeveloped countries

There is a shortage of trained healthcare professionals in developing countries. For example, according to the article published by BMJ Publishing Group Ltd in May 2019, in India, the density of the total health professional is estimated to be 29 per 10,000 populations; however, only 16 per 10,000 is the density of trained workers. In addition, the trained health workforce in India does not meet the minimum threshold of 22.8 skilled workers per 10,000 populations, which is recommended by the World Health Organization (WHO). Such unavailability of a skilled workforce to operate PFT systems associated with these systems are expected to obstruct the market growth during the forecast period.

COVID-19 Impact

The COVID-19 epidemic led to abridged demand for pulmonary function testing (PFT) systems during the forecast period, due to the prominent reduction in the implementation of PFT systems during the peak time of COVID-19. Nevertheless, after the easing of lockdown in a few nations, the PFT systems were reinstated in the healthcare units with RT-PCR tests. The government of every nation is procuring and manufacturing more mobile pulmonary function testing devices which are rapid as well as require less human contact. This has surely given a hike to market for pulmonary function testing share.

The portable PFT systems segment is expected to be the largest during the forecast period

The portable PFT systems segment is anticipated to have a lucrative growth, due to the increase in the adoption of portable systems in independent and diagnostics clinics, increasing launches of these products for the diagnosis of asthma and COPD, and rising air pollution.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to increasing espousal of complete systems for diagnosing patients in hospitals and the surging footfalls of COPD and asthma patients in the hospitals.

Region with highest share:

North America is projected to have the largest market share during the forecast period, due to rising technological advancements in diagnostics, well-developed healthcare infrastructure, increasing prevalence of chronic respiratory diseases, the prompt implementation of portable systems and the bolstering usage of these devices in physician groups (clinics) in the region, and rising hospital admissions.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to growing footprints of market players in developing countries of Asia Pacific, growing emphasis on enhancing hospital infrastructure, rising awareness regarding the usage of pulmonary function tests, and increasing demand for pulmonary function testing devices in private hospitals and clinics in the region.

Key players in the market

Some of the key players profiled in the Pulmonary Function Testing System Market include NSPIRE HEALTH INC., Koninklijke Philips N.V., COSMED Srl, Omron Healthcare, Inc., Morgan Scientific Inc., Becton, Dickinson and Company., Schiller AG, PulmOne, Vyaire Medical, Inc, Minato Holdings Inc., MGC Diagnostic Corporation, 3M, Ganshorn Medizin Electronic, Data Sciences International, and Medline Industries.

Key Developments:

In September 2020, PulmOne Advanced Medical Devices announced the launch of MiniBox Academy, an innovative, self-paced e-learning training and certification program for MiniBox+ customers. The academy is designed to improve PFT testing expertise, ensure testing consistency, reproducibility, and accuracy and facilitate an outstanding patient experience.

In March 2018, COSMED Srl launched altogether new catalogue of products for monitoring and screening of pulmonary function testing.

In October 2017, Vyaire Medical, Inc. formed an acquisition over Revolutionary Medical Devices, Inc. they manufacture products for smoothing the functioning of air passage inside the human body.

In September 2016, Schiller AG threw into orbit their device called touch 7. It was more efficient in detecting the problems in pulmonary functioning.

Types Covered:

  • Complete PFT Systems
  • Portable PFT Systems

Components Covered:

  • Hardware
  • Software
  • Service

Test Types Covered:

  • Lung Volume
  • Spirometry
  • Gas Exchange Testing
  • High Altitude Simulation Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • Stethoscope
  • Peak Flow Meter

Techniques Covered:

  • Helium Dilution
  • Nitrogen Washout
  • Plethysmography

Applications Covered:

  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
  • Preoperative Testing
  • Chronic Obstructive Pulmonary Disease
  • Impairment or Disability
  • Early Morning Wheezing

End Users Covered:

  • Physical Examination (Diagnostic) Centers
  • Hospitals
  • Physician Groups (Clinics)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pulmonary Function Testing System Market, By Type

  • 5.1 Introduction
  • 5.2 Complete PFT Systems
  • 5.3 Portable PFT Systems

6 Global Pulmonary Function Testing System Market, By Component

  • 6.1 Introduction
  • 6.2 Hardware
  • 6.3 Software
  • 6.4 Service

7 Global Pulmonary Function Testing System Market, By Test Type

  • 7.1 Introduction
  • 7.2 Lung Volume
  • 7.3 Spirometry
  • 7.4 Gas Exchange Testing
  • 7.5 High Altitude Simulation Testing
  • 7.6 Maximal Voluntary Ventilation
  • 7.7 Oxygen Titration Test
  • 7.8 Stethoscope
  • 7.9 Peak Flow Meter

8 Global Pulmonary Function Testing System Market, By Technique

  • 8.1 Introduction
  • 8.2 Helium Dilution
  • 8.3 Nitrogen Washout
  • 8.4 Plethysmography

9 Global Pulmonary Function Testing System Market, By Application

  • 9.1 Introduction
  • 9.2 Asthma
  • 9.3 Chronic Shortness of Breath
  • 9.4 Restrictive Lung Disease
  • 9.5 Preoperative Testing
  • 9.6 Chronic Obstructive Pulmonary Disease
  • 9.7 Impairment or Disability
  • 9.8 Early Morning Wheezing

10 Global Pulmonary Function Testing System Market, By End User

  • 10.1 Introduction
  • 10.2 Physical Examination (Diagnostic) Centers
  • 10.3 Hospitals
  • 10.4 Physician Groups (Clinics)

11 Global Pulmonary Function Testing System Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 NSPIRE HEALTH INC.
  • 13.2 Koninklijke Philips N.V.
  • 13.3 COSMED Srl
  • 13.4 Omron Healthcare, Inc.
  • 13.5 Morgan Scientific Inc.
  • 13.6 Becton, Dickinson and Company.
  • 13.7 Schiller AG
  • 13.8 PulmOne
  • 13.9 Vyaire Medical, Inc
  • 13.10 Minato Holdings Inc.
  • 13.11 MGC Diagnostic Corporation
  • 13.12 3M
  • 13.13 Ganshorn Medizin Electronic
  • 13.14 Data Sciences International
  • 13.15 Medline Industries

List of Tables

  • Table 1 Global Pulmonary Function Testing System Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Pulmonary Function Testing System Market Outlook, By Type (2020-2028) ($MN)
  • Table 3 Global Pulmonary Function Testing System Market Outlook, By Complete PFT Systems (2020-2028) ($MN)
  • Table 4 Global Pulmonary Function Testing System Market Outlook, By Portable PFT Systems (2020-2028) ($MN)
  • Table 5 Global Pulmonary Function Testing System Market Outlook, By Component (2020-2028) ($MN)
  • Table 6 Global Pulmonary Function Testing System Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 7 Global Pulmonary Function Testing System Market Outlook, By Software (2020-2028) ($MN)
  • Table 8 Global Pulmonary Function Testing System Market Outlook, By Service (2020-2028) ($MN)
  • Table 9 Global Pulmonary Function Testing System Market Outlook, By Test Type (2020-2028) ($MN)
  • Table 10 Global Pulmonary Function Testing System Market Outlook, By Lung Volume (2020-2028) ($MN)
  • Table 11 Global Pulmonary Function Testing System Market Outlook, By Spirometry (2020-2028) ($MN)
  • Table 12 Global Pulmonary Function Testing System Market Outlook, By Gas Exchange Testing (2020-2028) ($MN)
  • Table 13 Global Pulmonary Function Testing System Market Outlook, By High Altitude Simulation Testing (2020-2028) ($MN)
  • Table 14 Global Pulmonary Function Testing System Market Outlook, By Maximal Voluntary Ventilation (2020-2028) ($MN)
  • Table 15 Global Pulmonary Function Testing System Market Outlook, By Oxygen Titration Test (2020-2028) ($MN)
  • Table 16 Global Pulmonary Function Testing System Market Outlook, By Stethoscope (2020-2028) ($MN)
  • Table 17 Global Pulmonary Function Testing System Market Outlook, By Peak Flow Meter (2020-2028) ($MN)
  • Table 18 Global Pulmonary Function Testing System Market Outlook, By Technique (2020-2028) ($MN)
  • Table 19 Global Pulmonary Function Testing System Market Outlook, By Helium Dilution (2020-2028) ($MN)
  • Table 20 Global Pulmonary Function Testing System Market Outlook, By Nitrogen Washout (2020-2028) ($MN)
  • Table 21 Global Pulmonary Function Testing System Market Outlook, By Plethysmography (2020-2028) ($MN)
  • Table 22 Global Pulmonary Function Testing System Market Outlook, By Application (2020-2028) ($MN)
  • Table 23 Global Pulmonary Function Testing System Market Outlook, By Asthma (2020-2028) ($MN)
  • Table 24 Global Pulmonary Function Testing System Market Outlook, By Chronic Shortness of Breath (2020-2028) ($MN)
  • Table 25 Global Pulmonary Function Testing System Market Outlook, By Restrictive Lung Disease (2020-2028) ($MN)
  • Table 26 Global Pulmonary Function Testing System Market Outlook, By Preoperative Testing (2020-2028) ($MN)
  • Table 27 Global Pulmonary Function Testing System Market Outlook, By Chronic Obstructive Pulmonary Disease (2020-2028) ($MN)
  • Table 28 Global Pulmonary Function Testing System Market Outlook, By Impairment or Disability (2020-2028) ($MN)
  • Table 29 Global Pulmonary Function Testing System Market Outlook, By Early Morning Wheezing (2020-2028) ($MN)
  • Table 30 Global Pulmonary Function Testing System Market Outlook, By End User (2020-2028) ($MN)
  • Table 31 Global Pulmonary Function Testing System Market Outlook, By Physical Examination (Diagnostic) Centers (2020-2028) ($MN)
  • Table 32 Global Pulmonary Function Testing System Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 33 Global Pulmonary Function Testing System Market Outlook, By Physician Groups (Clinics) (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.